We Are LC Sciences
- Headquarters in Houston, Texas – USA
- Offices in USA & China
- Representatives in Europe, Japan, Korea, & India
- Customers in > 40 countries
- First microRNA microarray service provider (since 2005)
- Leading position in customer publications in peer reviewed journals
What We Do
While some recent breakthrough discoveries have provided answers to long standing questions, others have raised even more basic biological questions. There still remains a vast need for understanding many significant pathologies at the genomic level. LC Sciences provides comprehensive services to the academic and biotech communities that are designed to be one-stop and produce the results needed to quickly advance our customers’ biological and biomedical research.
Development of novel clinical diagnostics and molecular medicines is key to fulfilling the promise of personalized medicine for treating cancer, heart disease, neurological disorders and other significant diseases. The identification of novel biomarkers based on disease-related genes, genetic mutations, and known genomes of infectious viruses and pathogens will require integrated technology platforms such as those developed at LC Sciences.
The study of key traits such as plant growth and development, stress response, hybrid vigor, and reproduction at the genomic level will be essential for agronomic advancement. Though new focus on agriculture has provided a large amount of new genomic information and tools, there still remains a challenge of working with non-model, highly varied species. LC Sciences’ innovative products and comprehensive services are based on in-house developed parallel-synthesis and targeted sequencing technologies that offer unprecedented flexibility and customization capability.
Our Latests Successes
- Molecular Inversion Probes Used to Study Loss of Function Sequence Variation in Phospholipase A2-Activating Protein Encoding Gene
- New RNA-Seq Data Provides Important Insight Into the Pathogenic Mechanism of Hepatitis E Virus
- Knockdown of Let-7a Identified as Potential Strategy to Improve MSC Therapy for Inflammatory Diseases
- Degradome Sequencing Suggests tsRNA Regulate Gene Expression Through Sequence-Specific Degradation of Target RNAs
- Seasonal Changes in the Expression of P450arom and Estrogen Receptors May Be Involved in Regulation of Scented Gland
- New Insight Into the Underlying Molecular Mechanisms of Toll Signaling
- Alcohol Implicated in Malignant Progression of Breast Cancer